Daily Judi: Tuesday, October 18, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Despite better quarterly earnings than expected, Reuters reports that Johnson & Johnson may still cut jobs as it contends with global financial pressure.
In Europe, epidemiologists are countering misinformation concerning Pfizer's COVID-19 vaccine trials. (People)
Zachary Brennan reports on a group of U.S. senators' letter to the National Institutes of Health and the public's "access to timely trial results." (Endpoints News)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
"My favorite thing about working for AG Mednet is its diversity; the potential to grow, and to learn."
–Sirisha, Software Engineer
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.